Cholangiocarcinoma (CCA) comprises a heterogeneous group of biliary malignant tumors with dismal prognosis. Its incidence is increasing globally, and a raising trend of mortality has been reported. The first-line treatment for advanced CCA [cisplatin (CisPt) and gemcitabine] is considered palliative due to the high chemoresistance of this cancer, barely impacting
27/01/23
Electromagnetic stimulation as new treatment for stroke and other neurological diseases
.
16/12/22
Cost- effectiveness analysis of vaccines for COVID-19 according to gender, comorbidity and socioeconomic level: a population study
.
01/12/22
The role of the scavenger receptor MARCO in the immune-oncology of cholangiocarcinoma
.
25/11/22
Generation of new LGMDR1 models with CRISPR/Cas9 and studies to expand insight into the disease
.
18/11/22
in vitro human skeletal muscle platforms for the evaluation of functional outcomes
.
11/11/22
Progranulina y regulación del metabolismo y reciclaje celular en neurodegeneración
.
07/11/22
The role of transcription factor KLF15 in the etiopathogenesis of biliary cancer: new diagnostic, prognostic and therapeutic strategy
.